Co-Diagnostics, Inc. (CODX) had an exceptional day on Wednesday. I have been telling you that this swing was ready to take off and it did. Once it got through the level around 13-13 1/2, it popped, stalled, and then on Wednesday it exploded 6.42, or 38%, to 23.42, after reaching a multi-week and session high of 23.50, on 21.3 million shares traded. It was up an additional 3.33 to 26.75 in after-hours. It looks like it might accelerate here. I want to see if it will run up to the high 30’s, low 40’s next.

Inovio Pharmaceuticals, Inc. (INO) extended its move for the fourth day in a row on Wednesday, gaining 47 cents, or 3.64%, to 13.37, with a session high of 13.85, on 38.6 million shares traded, and another 11 cents in after-hours. It looks to me like it’s going to make a run at the 16-16 1/2 range short term.

Progyny, Inc. (PGNY), company specializing in fertility and family building management and benefits solution, broke out of a base on Wednesday with a breakaway gap and soared 5.64, or 27.5%, to 26.13, with a session high of 27.49, on 5.2 million shares traded, and another 27 cents in after-hours. That’s the biggest volume traded since its IPO days back in October. Some resistance occurred around 29, which is the near-term target, and a secondary target is in the mid 30’s may be doable.

Translate Bio, Inc. (TBIO) has been breaking out of a base, and formed a big engulfing bar on Wednesday, advancing 2.00, or 14.6%, to 15.67, with a multi-week and session high of 15.95, on nearly a million shares traded, and an additional 24 cents higher in after-hours. I think this stock has designs on higher levels. The parallel angle channel tells me that this might be an 18-19-dollar stock.

Upwork Inc. (UPWK), an online website for freelancers and agencies searching for employment and employees, exploded on Tuesday and followed through on Wednesday to right at the gap at resistance, jumping 1.29, or 10 1/2%, to 13.58, with a session high of 13.60, on 8.3 million shares traded, and then made a big thrust to 14 1/2 in after-hours. We’ll be watching this one on Thursday for a move that might test 15 1/2.

vTv Therapeutics Inc. (VTVT) broke out on Tuesday and closed above the breakout point, and on Wednesday, it reached secondary resistance and blew through that, popping 63 cents, or 25%, to 3.19, with a session high of 3.31, on 2.7 million shares traded and another 10 cents higher in after-hours. My target now is 4-4 1/4. Secondary target is up around 6.

Stocks on the long side included Altimmune, Inc. (ALT), Co-Diagnostics, Inc. (CODX), Creative Realities, Inc. (CREX), Immune Therapeutics, Inc. (IMUN), Inovio Pharmaceuticals, Inc. (INO), Moderna, Inc. (MRNA), Natural Grocers by Vitamin Cottage, Inc. (NGVC), NanoViricides, Inc. (NNVC), Overstock.com, Inc. (OSTK), Progyny, Inc. (PGNY), PGT Innovations, Inc. (PGTI), Revolve Group, Inc. (RVLV), Translate Bio, Inc. (TBIO), United Natural Foods, Inc. (UNFI), Upwork Inc. (UPWK), VectoIQ Acquisition Corp. (VTIQ), and vTv Therapeutics Inc. (VTVT).